Inhibition of tumor angiogenesis by TTF1 from extract of herbal medicine

Figure 2 Inhibitory effect of TTF1 on HepG-2 cell-induced angiogenesis in chorioallantoic membrane. A: Control, inoculated with normal saline; B: Inoculated with HepG-2 cells; C: Inoculated with HepG-2 cells and treated with TTF1; D and E: Different doses of compound were used as treatments in the HepG-2 cell-induced angiogenesis in chorioallantoic membrane (CAM) as follows: sTTF1 (25 μg/embryo × 5 d); mTTF1 (50 μg/embryo × 5 d); lTTF1 (100 μg/embryo × 5 d); apigenin (100 μg/embryo × 5 d); and Con (control group treated with normal saline). ^aP < 0.05, ^bP < 0.01 vs control group.